have shown that the proportion of CD62LhighCD25+CD4+ Tregs (Figure 1) is significantly higher in extended‐stage disease SCLC, whereas there are more CD62LlowCD4+ T cells in limited‐stage SCLC (LD‐SCLC).100. Here, CD4 is linked to small cell lung carcinoma.